Rosenberg named CEO of Rodin Therapeutics
Adam J. Rosenberg was named CEO of Rodin Therapeutics and will also be appointed the company’s board. Rosenberg most recently served as co-founder, director and CEO of Teleos Therapeutics. Atlas Venture and Proteros Biostructures co-founded Rodin, a biotechnology company that aims to discover and develop therapeutics for cognitive disorders, in 2013.
6 October 2015•3 mins read
